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Modeling the Structural Consequences of BEST1 Missense Mutations
Abstract
Mutations in the bestrophin-1 gene (BEST1) are an important cause of inherited retinal disorders.
Hitherto, over 100 unique allelic variants have been linked to the human BEST1 (hBEST1), and associated
with disease phenotypes, broadly termed as bestrophinopathies. A spontaneous animal model
recapitulating BEST1-related phenotypes, canine multifocal retinopathy (cmr), is caused by mutations in
the canine gene ortholog (cBEST1). We have recently characterized molecular consequences of cmr,
demonstrating defective protein trafficking as a result of G161D (cmr2) mutation. To further investigate
the pathological effects of BEST1 missense mutations, canine and human peptide fragments derived
from the protein sequence have been studied in silico as models for early events in the protein folding.
The results showed that G161D as well as I201T substitutions cause severe conformational changes in the
structure of bestrophin-1, suggesting protein misfolding as an underlying disease mechanism. The
comparative modeling studies expand our insights into BEST1 pathogenesis.
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78.1 Introduction
Bestrophinopathies are a group of inherited retinal disorders primarily caused by point
mutations scattered throughout the entire BEST1 gene. In humans, most of these sequence
alterations lead to Best vitelliform macular dystrophy (BVMD), and in dogs cause cmr, a
retinal phenotype modeling BVMD (Guziewicz et al. 2007, 2011; Zangerl et al. 2010).
The BEST1 gene product, bestrophin-1 (Best1), is embedded in the basolateral plasma
membrane of the RPE, where it functions as a Ca 2+ dependent anion channel (Marmorstein
et al. 2000; Hartzell et al. 2008). Two different topological models of human bestrophin-1
(hBest1) have been proposed. Based on the hydropathy profile analysis, Tsunenari et al.
predicted six hydrophobic domains with five transmembrane-spanning segments for the
native hBest1 (Tsunenari et al. 2003). Milenkovic et al. proposed a plausible alternative
model with four membrane-spanning regions that places residues 95–229 within the
cytoplasmic matrix, forming an extensive intracellular loop (Milenkovic et al. 2007). Both
models locate the N and C termini on the cytosolic side, and both predict transmembrane
domains within the highly evolutionarily conserved N-terminal part of the protein.
Although remarkable progress has been made toward understanding the bestrophin-1
physiology (Sun et al. 2002; Yu et al. 2007; Milenkovic et al. 2007; Qu et al. 2009), our
understanding of its complex function and pathological mechanism is still at an early stage.
Hitherto, the molecular consequences of altered residues defining three mutational hotspots
of the bestrophin-1 molecule (6–30aa, 80–105aa, and 293–312aa) have been the most
extensively studied (for review see Hartzell et al. 2008; Boon et al. 2009). These studies
established a primary link between BEST1 mutations and the anion channel malfunction, and
provided multiple clues how a particular amino acid substitution may interfere with the
protein functionality. In most cases, diminished or absent Cl− current, altered anion
permeability or defective membrane integration in association with bestrophinopathies have
been reported (Hartzell et al. 2008; Boon et al. 2009; Xiao et al. 2010). Despite the
indisputable advancements made in elucidation of bestrophin-1 pathogenic effects,
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expression and molecular kinetics of mutant transcripts, potential structural consequences,
and its impact on the intracellular processing, were either not examined at all or just outlined
in few cases (Hartzell et al. 2008; Boon et al. 2009).
We previously described three spontaneous canine bestrophin-1 (cBest1) mutations
responsible for cmr, an autosomal recessive retinal disorder recognized in numerous dog
breeds (Guziewicz et al. 2007; Zangerl et al. 2010). The distinct sequence alterations in
cBEST1 include a nonsense transition (C73T/R25X) located in the first coding exon (cmr1), a
missense substitution (G482A/G161D) affecting a conserved glycine residue (cmr2), and a
frameshift mutation (C1388del/P463FS) resulting in a truncated protein shortened by 92 Cterminal aa (cmr3) (Guziewicz et al. 2007; Zangerl et al. 2010). Detailed studies on
molecular consequences of cmr1 mutation verified the BEST1 null phenotype, where C73T/
R25X premature stop encodes for a truncated protein not detectable in the homozygous
mutant animals or in an in vitro model system (Guziewicz et al. 2011).
In the cmr2 model, the small (75 Da), neutral, and non-hydrophilic glycine residue at
position 161 is replaced by a much larger (133 Da) highly hydrophilic and negatively
charged aspartic acid. We speculated that this drastic amino acid change may cause
defective intracellular trafficking due to the incorrect folding of the mutant protein that
cannot pass the endoplasmic reticulum (ER) quality control system. Indeed, the in-depth
characterization of pathogenic effects of G482A/G161D revealed mislocalization of the cmr2bestrophin to the perinuclear space of the cells. Moreover, confocal immuno-fluorescence
microscopy analysis indicated co-localization of cmr2 mutant protein with an ER marker,
calnexin (Guziewicz et al. 2011). To further support our hypothesis on cmr2 protein
misfolding and retention in the ER, we used computational approaches to predict the
potential structural consequences of the G161D alteration.

78.2 Materials and Methods
78.2.1 Topology Prediction
Topological model of canine bestrophin-1 (NP_001091014) was predicted in silico using
Classification and Secondary Structure Prediction of Membrane Proteins SOSUI Server
v1.11 (http://bp.nuap.nagoya-u.ac.jp/sosui/; Hirokawa et al. 1998). The model was verified
by TopPred II algorithm (Transmembrane Topology Prediction of Membrane Proteins:
http://mobyle.pasteur.fr/cgi-bin/portal.py; Claros and von Heijne 1994). Transmembrane
segment hydrophobicity scores were calculated according to the GES scale with a cutoff of
(−c) 1.8 and (−p) 0.7 (Engelman et al. 1986).
78.2.2 Prediction of Protein Structure
Protein Homology/analogY Recognition Engine (PHYRE Server version 0.2) (http://
www.sbg.bio.ic.ac.uk/phyre/; Bennett-Lovsey et al. 2008) was used to perform the
secondary fold recognition analysis and tertiary structure prediction for cBest1 (1–296aa)
and hBest1 (25–301aa) protein segments. For the putative cBest1 wild-type (WT) structure
the estimated precision value (EPV) reached 85% with an e-value of 0.46; for the cmr2
mutant protein EPV of 75% and e-value of 0.7 was considered. The putative model
structures for hBest1 WT (EPV of 80%, e-value of 0.5) and hBest1 I201T mutant (EPV of
85%, e-value of 0.43) were compared to the canine specific predictions. All structures were
evaluated on 3D molecule viewer module of the Vector NTI™ 10 software package
(Invitrogen).
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78.3 Results
78.3.1 Canine Bestrophin-1 Topology
In silico analysis predicted four transmembrane-spanning regions for the native cBest1,
orienting the N and C termini to the cytoplasm (Fig. 78.1). According to the SOSUI
algorithm, the four most probable transmembrane segments are located at amino acids 32–
54, 73–94, 231–253, and 265–287. This model further predicts large, relatively hydrophobic
intracellular loop (95–230aa), harboring the G161 residue mutated in cmr2 (Fig. 78.1). To
test whether the location of the transmembrane domains is affected by the cmr2 mutation,
the G161D change was introduced into the protein sequence, and analyzed with the SOSUI
algorithm. No effect on the cBest1 topological model was noted with the G161D substitution.
The putative cBest1 topology model was verified by TopPred II algorithm (data not shown).
78.3.2 Comparative Protein Modeling
The highly evolutionarily conserved N-terminal part (1–296aa fragment) was used for
secondary and tertiary structure prediction of the native cBest1 or the G161D mutant variant
(Fig. 78.2). Figure 78.2c–d1 illustrates the detailed structural environment of the wild-type
residues in the native cBest1 in comparison to the cmr2 mutant model. Replacement of Gly
by Asp at position 161 dramatically affects protein structure leading to disrupted
intramolecular interactions of neighboring residues (Fig. 78.2b, d–d1). To assess the
relevance of the canine specific findings to human bestrophinopathies, a putative 3D
structure for hBest1 (25–301aa fragment) WT or comparable T602C/I201T mutant variant
associated with Best disease (Lotery et al. 2000) was predicted by the same algorithm (Fig.
78.3). Significant changes in the I201T mutant protein inducing conformational
rearrangements and altered inter-residue interactions are demonstrated in Fig. 78.3d–d1.
Note that only three-dimensional models of EPV ≥ 75% were considered.

78.4 Discussion
Membrane proteins play a crucial role in biological systems as ion channels, pores, and
receptors. Understanding their structure and dynamics is essential to expand our knowledge
on fundamental aspects of cellular homeostasis. However, only a small fraction of these
important proteins has been isolated so far, and the function of most still remains
ambiguous. Reasons for this lag include difficulties in expressing such proteins in significant
quantities, in isolating and purifying them considering their amphipathic character, and in
crystallizing them (http://www.che.udel.edu/cobre/). The recent rapid advances in computer
sciences have accelerated their applications to understand complex biological systems,
which helped to tackle some of the experimental difficulties. As a consequence, theoretical
simulations and computational design methods are now an integral part of biomedical
research, becoming an exceptionally useful and powerful means for studying membrane
proteins architecture and properties (Casadio et al. 2003). We used two independent
computational topology algorithms to assess the putative topology model for cBest1 (Fig.
78.1). Our in silico prediction strongly supports the experimental hBest1 topology model of
Milenkovic et al. (2007), which further suggests similar topology for all vertebrate
bestrophins. Both models consist of four transmembrane domains in the N-terminus of the
protein, separated by a larger intracellular loop, and orienting the C-terminus toward the
cytosol (Fig. 78.1; Milenkovic et al. 2007).
The majority of the disease-causing missense mutations identified in humans affect folding
or trafficking, rather than specifically affecting protein function (Sanders and Myers 2004).
To date, all examined missense changes in the hBest1 were associated with functional
consequences, implicating an impaired channel activity. This study demonstrates the
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potential structural consequences of G161D (cmr2) and comparable hBest1 point mutation,
I201T, predicted by comparative modeling of the N-terminal part of bestrophin-1. Both
analyzed mutations are substitutions replacing a highly evolutionary conserved amino acid
with a much bulkier residue (cmr2) of different biochemical properties (cmr2, I201T). Such
dramatic changes often affect structure of the encoded protein in the immediate vicinity of
the residue, creating electrostatic disturbances and altering the intramolecular inter-actions
(Figs. 78.2c1, d1 and 78.3c1, d1).
The predicted structural rearrangements caused by G161D are in good agreement with
previous experiments. Wild type cBest1 is processed in the ER and targeted to the plasma
membrane, reflecting normal biogenesis and trafficking of bestrophin-1, but the cmr2
mutant is retained in the ER (Guziewicz et al. 2011). These data indicate that at least a
subset of BEST1 missense mutations may lead to the protein misassembly, and its build-up
in the ER. Since the BVMD and cmr are disorders where subretinal deposits accumulate,
this mechanism may have an influence on the nature of lesions observed as well as on the
disease progression. To support this hypothesis detailed studies are required to further
analyze the molecular changes in the early events of the structurally defective bestrophin-1
folding.
Bestrophins are recognized as one of the most mysterious proteins of all known ion
channels. To date, Best1 function and kinetics are still not fully understood. Our studies
provided new insights into molecular pathology of point mutations associated with cmr and
Best disease, which is central to the pathogenesis of bestrophinopathies. Additional studies
will be required to explore the biochemical and cellular consequences of BEST1 mutations,
and clarify their impact on protein structure with relation to disease onset and progression.
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Fig. 78.1.

A representative model of canine bestrophin-1 topology. Two independent computational
algorithms (SOSUI, TopPred II) were used to estimate the number of transmembrane
domains of the cBest1. Both, the hydropathy index of Kyte and Doolittle and the Goldman,
Engelman, and Steitz (GES) hydrophobicity scale, predict four cBest1 transmembrane
segments
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Fig. 78.2.

3D representation of the native and cmr2 mutant 295aa long N-terminal cBest1 fragment. (a,
b) Overview of the tertiary structure predictions; structural changes caused by G161D
substitution are indicated by arrows. (c, d) Detailed structural environment of the wild-type
residues in the native cBest1 (c) in comparison to the cmr2 mutant (d). Amino acids G161
(WT) and D161 (cmr2) are highlighted in yellow. (c1, d1) Higher resolution views of the
regions denoted by the white square in (c) and (d); Note the significant changes in the amino
acid constellations induced by G161D replacement. Color code bar: negatively charged aa
are labeled in red, whereas positively charged are marked in blue
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Fig. 78.3.

Computational prediction of 3D models for the native hBest1 and I201T mutant variant
(amino acids 25–301). Arrows indicate position of I201 WT residue (a) and T201 mutant (b).
Panels (c, d) illustrate details of the putative tertiary structure calculated for the native
hBest1 (c) vs. I201T mutant (d); (c1 ) and (d1 ) show magnifications of the portion denoted
by the white square in the images (c) and (d). Wild-type residue I201 and mutant T201 are
highlighted in yellow. Note the striking rearrangement of molecular interactions surrounding
the T201 residue (d1 ). Color code bar: negatively charged aa are labeled in red, whereas
positively charged are marked in blue
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